IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q1 FY25 results · Apr–Jun 2024
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹502.38 crore (down 10.8% from Q1 FY24) and net profit of ₹29.97 crore (down 34.6% from Q1 FY24) for Q1 FY25 (Apr–Jun 2024), on a consolidated basis.
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 502.38 | 563.18 | −10.8% | 503.92 | −0.3% |
| Other income | 7.38 | 7.06 | +4.5% | 7.52 | −1.9% |
| Total income | 509.76 | 570.24 | −10.6% | 511.44 | −0.3% |
| Profit before tax | 39.52 | 61.18 | −35.4% | 37.20 | +6.2% |
| Net profit for the period | 29.97 | 45.86 | −34.6% | 27.62 | +8.5% |
| EPS, basic (₹) | 5.11 | 7.81 | −34.6% | 4.71 | +8.5% |
| Net margin (%) | 6.0 | 8.1 | 5.5 |
| Item | Q1 FY25 | Q1 FY24 | YoY | Q4 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 502.38 | 563.18 | −10.8% | 503.92 | −0.3% |
| Other income | 7.38 | 7.06 | +4.5% | 7.52 | −1.9% |
| Total income | 509.76 | 570.24 | −10.6% | 511.44 | −0.3% |
| Profit before tax | 39.23 | 61.53 | −36.2% | 37.77 | +3.9% |
| Net profit for the period | 29.68 | 46.21 | −35.8% | 28.19 | +5.3% |
| EPS, basic (₹) | 5.06 | 7.87 | −35.7% | 4.80 | +5.4% |
| Net margin (%) | 5.9 | 8.2 | 5.6 |
Consolidated
- Filed with BSE
- 13 Aug 2024, 11:53 IST
- Board meeting
- 09 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 Aug 2024, 11:53 IST
- Board meeting
- 09 Aug 2024
- Period
- 01 Apr 2024 to 30 Jun 2024
- Review status
- Unaudited
- Source
- XBRL filing on BSE